Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD.

HNF4a NAFLD NASH PPARg mathematical modeling phenotypic plasticity systems biology

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
22 Mar 2020
Historique:
received: 18 02 2020
revised: 15 03 2020
accepted: 18 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 3 4 2020
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in adults and children. It is characterized by excessive accumulation of lipids in the hepatocytes of patients without any excess alcohol intake. With a global presence of 24% and limited therapeutic options, the disease burden of NAFLD is increasing. Thus, it becomes imperative to attempt to understand the dynamics of disease progression at a systems-level. Here, we decoded the emergent dynamics of underlying gene regulatory networks that were identified to drive the initiation and the progression of NAFLD. We developed a mathematical model to elucidate the dynamics of the HNF4α-PPARγ gene regulatory network. Our simulations reveal that this network can enable multiple co-existing phenotypes under certain biological conditions: an adipocyte, a hepatocyte, and a "hybrid" adipocyte-like state of the hepatocyte. These phenotypes may also switch among each other, thus enabling phenotypic plasticity and consequently leading to simultaneous deregulation of the levels of molecules that maintain a hepatic identity and/or facilitate a partial or complete acquisition of adipocytic traits. These predicted trends are supported by the analysis of clinical data, further substantiating the putative role of phenotypic plasticity in driving NAFLD. Our results unravel how the emergent dynamics of underlying regulatory networks can promote phenotypic plasticity, thereby propelling the clinically observed changes in gene expression often associated with NAFLD.

Identifiants

pubmed: 32235813
pii: jcm9030870
doi: 10.3390/jcm9030870
pmc: PMC7141525
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Science and Engineering Research Board
ID : SB/S2/RJN-049/2018

Références

J Biol Chem. 2004 Mar 26;279(13):12027-35
pubmed: 14722127
J Hepatol. 2018 May;68(5):1033-1048
pubmed: 29175243
Stem Cells Transl Med. 2018 Nov;7(11):792-805
pubmed: 30272835
Cell. 2011 Mar 18;144(6):910-25
pubmed: 21414483
Nature. 2004 Feb 19;427(6976):737-40
pubmed: 14973486
Int J Mol Sci. 2013 Oct 09;14(10):20112-30
pubmed: 24113587
Sci Rep. 2015 Dec 02;5:17379
pubmed: 26627083
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4333-7
pubmed: 9539737
J Lipid Res. 2014 Aug;55(8):1702-10
pubmed: 24927728
Phys Biol. 2019 Sep 06;16(6):066004
pubmed: 31342918
World J Gastroenterol. 2018 Apr 21;24(15):1601-1615
pubmed: 29686467
J Hepatol. 2018 Feb;68(2):268-279
pubmed: 29122391
Nat Rev Gastroenterol Hepatol. 2020 Jan;17(1):40-52
pubmed: 31641249
Trends Genet. 2011 Feb;27(2):55-62
pubmed: 21146896
NPJ Syst Biol Appl. 2018 Aug 20;4:33
pubmed: 30131870
Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):369-384
pubmed: 29482963
Int J Mol Sci. 2018 Mar 19;19(3):
pubmed: 29562725
Biochem Pharmacol. 2016 Dec 15;122:62-71
pubmed: 27836672
Cell Metab. 2012 Oct 3;16(4):414-9
pubmed: 23000402
Gastroenterology. 2020 Feb 8;:
pubmed: 32044314
Hepatology. 2019 Aug;70(2):666-681
pubmed: 30520062
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20
pubmed: 28930295
J Clin Exp Hepatol. 2015 Jun;5(2):123-6
pubmed: 26155039
Asian J Androl. 2016 Sep-Oct;18(5):704-10
pubmed: 27427552
Genes (Basel). 2019 Nov 24;10(12):
pubmed: 31771247
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5987-92
pubmed: 9600904
Scand J Gastroenterol. 2009;44(4):471-7
pubmed: 19058085
J Biol Chem. 2001 Sep 28;276(39):36431-7
pubmed: 11477106
Cell Rep. 2016 Nov 1;17(6):1671-1682
pubmed: 27806304
Trends Pharmacol Sci. 2019 Jul;40(7):506-516
pubmed: 31160124
J Biol Chem. 2010 Feb 12;285(7):4725-31
pubmed: 20018873
J Biol Chem. 2015 Feb 13;290(7):4047-58
pubmed: 25540198
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6890-6900
pubmed: 32152092
PLoS Comput Biol. 2008 Nov;4(11):e1000235
pubmed: 19043543
Cancer Converg. 2017;1(1):2
pubmed: 29623961
Liver Res. 2018 Dec;2(4):209-215
pubmed: 31245168
Hepatol Int. 2013 Aug 30;7 Suppl 2:771-81
pubmed: 24587847
Annu Rev Pathol. 2018 Jan 24;13:321-350
pubmed: 29414249
Int J Mol Sci. 2018 Dec 10;19(12):
pubmed: 30544653
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):167-228
pubmed: 31852635
Mol Cell Biol. 1999 Aug;19(8):5495-503
pubmed: 10409739
Cell. 1994 Dec 30;79(7):1147-56
pubmed: 8001151
Genes Dev. 2000 Feb 15;14(4):464-74
pubmed: 10691738
Mol Syst Biol. 2006;2:2006.0017
pubmed: 16738562
J Clin Invest. 2017 May 1;127(5):1873-1888
pubmed: 28394260
PLoS Comput Biol. 2020 Feb 10;16(2):e1007619
pubmed: 32040502
Science. 2002 Aug 16;297(5584):1183-6
pubmed: 12183631
Gastroenterology. 2014 Mar;146(3):726-35
pubmed: 24316260
Curr Opin Genet Dev. 2001 Oct;11(5):568-74
pubmed: 11532400
Stem Cell Rev Rep. 2012 Mar;8(1):55-66
pubmed: 21365256
J Genet. 2019 Mar;98:
pubmed: 30945694
Front Endocrinol (Lausanne). 2017 May 22;8:102
pubmed: 28588550
Gut Liver. 2012 Apr;6(2):149-71
pubmed: 22570745
Nat Commun. 2018 Feb 15;9(1):689
pubmed: 29449567
Mol Endocrinol. 2009 Apr;23(4):434-43
pubmed: 19179483
PLoS One. 2017 Dec 7;12(12):e0189223
pubmed: 29216278
PLoS Comput Biol. 2017 Mar 31;13(3):e1005456
pubmed: 28362798
Mol Cell Biol. 2010 Feb;30(3):565-77
pubmed: 19933841
PLoS Comput Biol. 2016 Sep 15;12(9):e1005105
pubmed: 27632189
J Biol Chem. 2001 Mar 9;276(10):7062-8
pubmed: 11106650
PPAR Res. 2015;2015:347245
pubmed: 26693219
Hepatobiliary Surg Nutr. 2018 Dec;7(6):495-498
pubmed: 30652099
World J Hepatol. 2017 Jun 8;9(16):715-732
pubmed: 28652891
J Immunol Res. 2019 Jan 3;2019:3954890
pubmed: 30719457
Mol Cell Biol. 2001 Feb;21(4):1393-403
pubmed: 11158324
Genes Dev. 1996 May 1;10(9):1096-107
pubmed: 8654925
J Clin Endocrinol Metab. 2011 May;96(5):1424-30
pubmed: 21325464
PLoS Biol. 2013;11(8):e1001632
pubmed: 23976879
Mol Biosyst. 2017 Aug 22;13(9):1898-1911
pubmed: 28745372
Cell Metab. 2018 Apr 3;27(4):854-868.e8
pubmed: 29617644
J Clin Med. 2019 Sep 25;8(10):
pubmed: 31557977
Proteome Sci. 2016 Feb 03;14:3
pubmed: 26843850
J Biol Chem. 2012 Mar 2;287(10):7345-56
pubmed: 22241473
Front Pharmacol. 2020 Jan 08;10:1413
pubmed: 31969816
Int J Med Sci. 2018 Oct 20;15(14):1591-1599
pubmed: 30588181
PPAR Res. 2016;2016:6042162
pubmed: 27148361
Dis Model Mech. 2018 Sep 25;11(9):
pubmed: 30254132
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18144-9
pubmed: 24154725
Int J Clin Exp Med. 2014 Jul 15;7(7):1624-31
pubmed: 25126158
Hepatology. 2020 Apr;71(4):1213-1227
pubmed: 31442319
Dig Dis Sci. 2016 May;61(5):1282-93
pubmed: 26856717
Mol Oncol. 2017 Jul;11(7):739-754
pubmed: 28548388
FEBS Lett. 2017 Jul;591(13):1947-1957
pubmed: 28547778
World J Hepatol. 2015 Apr 28;7(6):846-58
pubmed: 25937862

Auteurs

Sarthak Sahoo (S)

Undergraduate Programme, Indian Institute of Science, Bangalore 560012, India.

Divyoj Singh (D)

Undergraduate Programme, Indian Institute of Science, Bangalore 560012, India.

Priyanka Chakraborty (P)

Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore 560012, India.

Mohit Kumar Jolly (MK)

Centre for BioSystems Science and Engineering, Indian Institute of Science, Bangalore 560012, India.

Classifications MeSH